Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 19 Carboplatin 11 Bevacizumab 11 Pemetrexed 8 Nivolumab 8 Temozolomide 6 Cisplatin 6 Cetuximab 6 atezolizumab 5 Standard of Care 5 Prednisone 5 Exercise 5 Dexamethasone 5 Cyclophosphamide 5 durvalumab 4 abemaciclib 4 Paclitaxel 4 Fluorouracil 4 Blood Specimen Collection 4 talazoparib 3 dostarlimab 3 daratumumab 3 cabozantinib 3 Rituximab 3 Oxaliplatin 3 Metformin 3 Leucovorin 3 Lenalidomide 3 Ipilimumab 3 Doxorubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × cobimetinib × 30 days × Clear all

NCT02693535 2026-05-29

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡